THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Biogen Idec is no longer for sale

Stock plunges after drug maker reports no definitive offers

By Todd Wallack
Globe Staff / December 13, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

Biogen Idec Inc. is taking down the "for sale" sign. The Cambridge biotechnology company yesterday said it has decided to remain independent, after failing to receive a single offer to buy the company. But it wasn't for lack of trying - over the past two months, Biogen Idec said, it had contacted every major drug company to see if any ... (Full article: 782 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass